Next Generation Gynecological Cancer Diagnostic Market by Technology
The Global Next Generation Gynecological Cancer Diagnostic Market size is expected to grow from USD 2.41 billion in 2022 to USD 5.43 billion by 2030, at a CAGR of 10.70% during the forecast period (2023-2030).
Cancer that originates in a woman's reproductive organs is referred to as gynecologic cancer. Cancer is always named after the body part where it first appears. Gynecologic cancers can start anywhere in a woman's pelvis, which is the area beneath the stomach and between hip bones. Cervical, ovarian, uterine, vaginal, and vulvar cancers are several types of gynecologic cancer. Ovarian cancer is the most common gynecologic cancer